Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
70.98+1.53 (+2.20%)
At close: 4:00PM EDT
70.98 0.00 (0.00%)
After hours: 04:20PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close69.45
Open69.45
Bid69.51 x 1000
Ask70.84 x 4000
Day's Range68.81 - 71.45
52 Week Range49.26 - 142.11
Volume389,963
Avg. Volume485,392
Market Cap3.622B
Beta (5Y Monthly)0.31
PE Ratio (TTM)56.65
EPS (TTM)1.25
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est79.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-21% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HAE

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Haemonetics Corporation
    HAE: Raising target price to $77.00HAEMONETICS CORP/MASS has an Investment Rating of BUY; a target price of $77.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
Advertisement
Advertisement